Related Experiment Video
Updated: Jul 18, 2025
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Treatment of High-Risk Neuroblastoma
Julie Krystal1, Jennifer H Foster2
1Zucker Hofstra School of Medicine, Department of Pediatrics, Cohen Children's Medical Center, New Hyde Park, NY 11040, USA.
Insights
High-risk neuroblastoma, a childhood cancer, has seen improved outcomes due to decades of research and clinical trials. This review details current treatment strategies for this aggressive solid tumor.
Area of Science:
- Pediatric Oncology
- Cancer Research
- Clinical Trials
Background:
- High-risk neuroblastoma is a prevalent and aggressive childhood cancer.
- Significant progress in treatment has been achieved over decades.
Purpose of the Study:
- To provide a comprehensive overview of current high-risk neuroblastoma treatments.
- To highlight advances in pediatric cancer therapy.
Main Methods:
- Literature review of clinical trials and research.
- Synthesis of current treatment protocols for high-risk neuroblastoma.
Main Results:
- Treatment advances have led to better outcomes for affected children.
- Current therapeutic strategies are detailed in the review.
Conclusions:
- Ongoing research and clinical trials are crucial for improving pediatric cancer survival.
- This review serves as a guide to contemporary high-risk neuroblastoma management.
Abstract:
High-risk neuroblastoma is a highly aggressive solid tumor that most commonly presents in early childhood. Advances in treatment through decades of clinical trials and research have led to improved outcomes. This review provides an overview of the current state of treatment for high-risk neuroblastoma.
